Manhattan Scientifics, Inc.
MHTX
$0.0001
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 158.00K | 189.00K | 149.00K | 177.00K | 181.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 160.00K | 192.00K | 151.00K | 180.00K | 186.00K |
| Operating Income | -160.00K | -192.00K | -151.00K | -180.00K | -186.00K |
| Income Before Tax | -158.00K | -382.00K | -254.00K | -262.00K | -229.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -158.00K | -382.00K | -254.00K | -262.00K | -229.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -158.00K | -382.00K | -254.00K | -262.00K | -229.00K |
| EBIT | -160.00K | -192.00K | -151.00K | -180.00K | -186.00K |
| EBITDA | -159.80K | -191.80K | -151.00K | -180.00K | -185.50K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 559.28M | 559.28M | 559.28M | 559.28M | 559.28M |
| Average Diluted Shares Outstanding | 559.28M | 559.28M | 559.28M | 559.28M | 559.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
